Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial

  • Peter A. Calabresi
  • , Gavin Giovannoni
  • , Hans Peter Hartung
  • , Robert T. Naismith
  • , Robert J. Fox
  • , Maria Pia Sormani
  • , Douglas L. Arnold
  • , Ludwig Kappos
  • , Martin Valis
  • , Scott D. Newsome
  • , Martin I. Belkin
  • , Emmanuel Bartholomé
  • , Katherine Riester
  • , Andrija Javor
  • , Jennifer Lyons
  • , Daniel P. Bradley
  • , Elizabeth Fisher
  • , Ian Tagge
  • , Maria L. Naylor
  • , Shibeshih Belachew
    • Aaron Deykin, Nathalie Franchimont, Bing Zhu, Wenting Cheng

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science